Ligand validation:6QJE

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 6QJE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QJE_GAL_A_401	78%	56%	0.122	0.964	0.74	0.92	-	-	0	0	100%	1
6QJE_GAL_B_401	74%	65%	0.117	0.949	0.46	0.87	-	-	0	0	100%	1
6QJE_GAL_C_401	38%	66%	0.173	0.874	0.48	0.81	-	-	0	0	100%	1
6ZGY_GAL_A_401	89%	26%	0.067	0.946	0.75	2.34	-	2	1	0	100%	1
6Q91_GAL_A_401	88%	23%	0.103	0.98	0.79	2.55	-	5	0	0	100%	1
6Q8Z_GAL_A_401	87%	5%	0.089	0.961	2.28	3.19	6	6	0	1	100%	1
6ZGX_GAL_E_401	85%	13%	0.095	0.962	0.93	3.15	-	5	0	0	100%	1
7OZX_GAL_B_401	81%	36%	0.108	0.959	0.74	1.85	-	2	1	0	100%	1
5ELB_GAL_C_202	100%	57%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
4WWH_GAL_B_401	100%	61%	0.047	0.993	0.51	0.97	-	1	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
2EUK_GAL_A_300	98%	59%	0.053	0.973	0.56	0.97	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.